PharVision Advisers’s Yext YEXT Stock Holding History

PharVision Advisers’s Portfolio YEXT Stock Details YEXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-18,518	Closed	-$157K	–	818
2025 Q2	$157K	Buy	+18,518	New	+$130K	0.23%	226

Other funds holding YEXT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LECM

Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return

LLL

Lynrock Lake LP Rye Brook, New York $1.46B AUM 17.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

PharVision Advisers's YEXT Position: Q3 2025 in Review

PharVision Advisers sold out of Yext (YEXT) in Q3 2025, closing a stake of 18,518 shares — an estimated $157K sold.

PharVision Advisers first reported a position in YEXT in Q2 2025 and held it in 1 quarter. The position peaked at $157K in Q2 2025. 199 funds tracked by Wall St. Rank hold YEXT as of Q3 2025.

PharVision Advisers reported no remaining Yext position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 18,518 Yext shares in Q3 2025, an estimated $157K.
PharVision Advisers first reported a position in Yext in Q2 2025 and held it in 1 quarter.
PharVision Advisers's Yext position peaked at $157K in Q2 2025.
199 funds tracked by Wall St. Rank held Yext as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.